William J. Link Phd
Director at Tarsus Pharmaceuticals; Director at LENSAR; Director at RxSight. Based in Irvine, California.
- Rank
- 8039th of 14,644
- Companies held
- 3
- Largest holding
- TARS, 72.6% of total
- Latest SEC filing
- Sep 15, 2026
What the $11.2M is made of
Holdings counted
All filings on SEC.gov| Company | How held | Shares | Price | Value | Share of total | Reported |
|---|---|---|---|---|---|---|
| Tarsus Pharmaceuticals TARS Common Stock | Directly | 94,487 | $77.67 | $7.3M | 65.4% | Form 4, Sep 15, 2026 |
| LENSAR LNSR Common Stock | Directly | 568,062 | $4.64 | $2.6M | 23.5% | Form 4, Jun 3, 2026 |
| Tarsus Pharmaceuticals TARS Common Stock | Through Link Family Enterprise, LP | 10,446 | $77.67 | $811K | 7.2% | Form 4, Sep 16, 2025 |
| RxSight RXST Common Stock | Directly | 74,892 | $4.61 | $345K | 3.1% | Form 4, Jun 17, 2026 |
| RxSight RXST Common Stock | Through Link Family Enterprise, L.P. | 21,248 | $4.61 | $98K | 0.9% | Form 4, Jun 17, 2026 |
Share counts are the amounts William J. Link Phd reported owning after each line of their latest filing for that company, adjusted for any later stock splits. Values use the latest price. Methodology.
Open-market trades, last 12 months
| Date | Trade | Company | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| Sep 15, 2026 | Sold | TARS | 66 | $80.01 | $5K | View |
| Sep 15, 2026 | Sold | TARS | 759 | $79.00 | $60K | View |
| Sep 15, 2026 | Sold | TARS | 11,675 | $78.33 | $915K | View |
| Jun 15, 2026 | Sold | TARS | 10,572 | $61.97 | $655K | View |
| Jun 15, 2026 | Sold | TARS | 1,928 | $62.94 | $121K | View |
| Mar 16, 2026 | Sold | TARS | 8,378 | $69.03 | $578K | View |
| Mar 16, 2026 | Sold | TARS | 493 | $69.75 | $34K | View |
| Mar 16, 2026 | Sold | TARS | 3,629 | $68.09 | $247K | View |
| Dec 15, 2025 | Sold | TARS | 5,046 | $80.80 | $408K | View |
| Dec 15, 2025 | Sold | TARS | 1,148 | $82.39 | $95K | View |
| Dec 15, 2025 | Sold | TARS | 5,680 | $80.71 | $458K | View |
| Dec 15, 2025 | Sold | TARS | 4,766 | $81.50 | $388K | View |
| Dec 15, 2025 | Sold | TARS | 6,306 | $81.75 | $516K | View |
Nearby on the list
Full list| Rank | Name | Stock holdings |
|---|---|---|
| 8036 | Lawrence E Harris Director, Interactive Brokers Group. Greenwich, CT | $11.2M |
| 8037 | John G. Mayer Director, TTM Technologies. Santa Ana, CA | $11.2M |
| 8038 | Kevin M. Stein Director, TransDigm Group. Philadelphia, PA | $11.2M |
| 8039 | William J. Link Phd Director, Tarsus Pharmaceuticals. Irvine, CA | $11.2M |
| 8040 | Larry G. Gerdes Director, CME Group. Chicago, IL | $11.2M |
| 8041 | Kyle J. Epley Chief Financial Officer, Caterpillar. Irving, TX | $11.2M |
| 8042 | Richard G. Harbison EVP, Refining, Phillips 66. Houston, TX | $11.2M |
Other Tarsus Pharmaceuticals insiders
All TARS insiders- Bobak R. Azamian$133MPresident/CEO and Board Chair. #1209 overall
- Michael Ackermann$102MDirector. #1484 overall
- Seshadri Neervannan$6.1MChief Operating Officer. #12564 overall
- Leonard Greenstein$2.1MChief Financial Officer. #13839 overall
- Bhaskar Chaudhuri$905KDirector. #4261 overall
- David E. I. Pyott$851KDirector. #9650 overall
Questions
How much stock does William J. Link Phd own?
William J. Link Phd holds $11,229,159 in listed stock based on SEC filings and current prices, mostly Tarsus Pharmaceuticals (TARS). That ranks 8039th on the Stock Rich List.
Is this William J. Link Phd's net worth?
No. It counts only listed shares reported on SEC Forms 3, 4 and 5. Cash, private companies, real estate, options and holdings that don't need to be reported are not included, so total net worth is likely different.
When did William J. Link Phd last buy or sell stock?
The most recent open-market trade on file is a sale of 66 TARS shares on Sep 15, 2026 at $80.01.